
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A global pharmaceutical company is seeking a Supply Chain Support Specialist to oversee inventory management, procurement coordination, and master data tasks. The candidate should possess strong analytical skills, attention to detail, and the ability to manage multiple priorities. This role involves tracking supplier performance, conducting stock audits, and maintaining documentation. Join the team to make a difference in rare disease treatments and enjoy a competitive salary, flexible work options, and comprehensive benefits.
Supply Chain Support Specialist
The Supply Chain Support Specialist is a multifaceted role combining elements of master data, procurement coordination, and inventory management to ensure the seamless flow of goods and materials throughout the organisation. The ideal candidate will possess strong analytical skills, attention to detail, and an ability to manage multiple priorities in a fast-paced environment. If you are keen to join a patient centric, high-growth company, then read on and apply today!
Essential Pharma is a global pharmaceutical company working to make a difference for patients in niche populations.
Everything at Essential Pharma is driven by the fact that every patient matters. We are focussed on developing and delivering medicines for patients in small, underserved or rare disease populations. Our team of 70+ people has an entrepreneurial spirit, challenging convention and working creatively to deliver results. Our headquarters are in Surrey, UK, and we have offices in Malta, France, Spain and Switzerland.
We are an international business, with a growing product portfolio that reaches patients in approximately 70 countries. We cover multiple therapy areas with a particular focus on rare disease, CNS, ophthalmology and gastroenterology. Our first development‑stage asset is an anti‑GD2 antibody for the treatment of high‑risk neuroblastoma. We have a proven track record of acquiring, investing in and commercialising treatments.